Paper · 6997121
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
Ebert R and 1 other. Diabetologia, 1980. Cited by 101 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Papers, record 6997121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6997121
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Celiac Disease | Major topic |
| Gastric Inhibitory Polypeptide | Major topic |
| Gastrointestinal Hormones | Major topic |
| Insulin | Major topic |
| Pancreatitis | Major topic |
| Adult | |
| Blood Glucose | |
| Chronic Disease | |
| Eating | |
| Female | |
| Humans | |
| Insulin Secretion | |
| Male | |
| Pancreatin |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07852988 | Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 Diabetes | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 428,820 | Release of motilin by oral and intravenous nutrients in man. | Gut | 1979 | https://conductscience.org/library/papers/428820 | PubMed |
| 2 | 4,423,791 | Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. | J Clin Endocrinol Metab | 1974 | https://conductscience.org/library/papers/4423791 | PubMed |
| 3 | 932,174 | The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. | J Clin Endocrinol Metab | 1976 | https://conductscience.org/library/papers/932174 | PubMed |
| 4 | 428,694 | The effect of oral galactose on GIP and insulin secretion in man. | Diabetologia | 1979 | https://conductscience.org/library/papers/428694 | PubMed |
| 5 | 385,455 | Duodenal endocrine cells in adult coeliac disease. | Gut | 1979 | https://conductscience.org/library/papers/385455 | PubMed |
| 6 | 128,084 | Identification and actions of gastric inhibitory polypeptide. | Recent Prog Horm Res | 1975 | https://conductscience.org/library/papers/128084 | PubMed |
| 7 | 32,119 | The incretin concept today. | Diabetologia | 1979 | https://conductscience.org/library/papers/32119 | PubMed |
| 8 | 428,832 | Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea. | Gut | 1979 | https://conductscience.org/library/papers/428832 | PubMed |
| 9 | 1,001,849 | Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis--relationship to endocrine and exocrine insufficiency. | Diabetologia | 1976 | https://conductscience.org/library/papers/1001849 | PubMed |
| 10 | 4,749,457 | Stimulation of insulin secretion by gastric inhibitory polypeptide in man. | J Clin Endocrinol Metab | 1973 | https://conductscience.org/library/papers/4749457 | PubMed |
1 to 10 of 30
See all 30 referencesCited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,820,968 | Interpreting beta cell function after total pancreatectomy with islet autotransplantation: the overlooked role of exocrine pancreatic function. | Diabetologia | 2026 | https://conductscience.org/library/papers/42820968 | PubMed |
| 42,162,477 | [Genetic, endocrine, drug-induced and pancreatogenic forms of diabetes and exocrine pancreatic insufficiency (Update 2026)]. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/42162477 | PubMed |
| 41,646,081 | Systematic Approach to Treatment of Chronic Pancreatitis. | Gastroenterol Hepatol (N Y) | 2026 | https://conductscience.org/library/papers/41646081 | PubMed |
| 39,246,884 | Ductal Intervention in Chronic Pancreatitis: Impact on Glycemic Control and Endocrine Insufficiency Management. | Cureus | 2024 | https://conductscience.org/library/papers/39246884 | PubMed |
| 38,331,895 | Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case-control study. | Diabetol Metab Syndr | 2024 | https://conductscience.org/library/papers/38331895 | PubMed |
| 37,410,209 | Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management. | Drugs | 2023 | https://conductscience.org/library/papers/37410209 | PubMed |
| 37,101,022 | [Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)]. | Wien Klin Wochenschr | 2023 | https://conductscience.org/library/papers/37101022 | PubMed |
| 35,819,935 | Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India. | PLoS One | 2022 | https://conductscience.org/library/papers/35819935 | PubMed |
| 34,386,397 | Exocrine Pancreatic Dysfunction in Diabetes: An Observational Study. | Indian J Endocrinol Metab | 2021 | https://conductscience.org/library/papers/34386397 | PubMed |
| 33,250,773 | Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What's Known and What's to Know. | Front Physiol | 2020 | https://conductscience.org/library/papers/33250773 | PubMed |
1 to 10 of 39
See all 39 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GIP | 2,695 | PubTator's text mining | https://conductscience.org/library/genes/2695 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6997121
GET https://conductscience.org/api/papers/v1/6997121/references?page=2